Truncated GLP-1 (proglucagon 78–107-amide) inhibits gastric and pancreatic functions in man (original) (raw)
References
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF: Preproglucagon gene expression in pancreas and intestine diversifies at the level of posttranslational processing. J Biol Chem 261:11880–11886, 1986 Google Scholar
Novak U, Wilks A, Buell G, McEven S: Identical mRNA for preproglucagon in pancreas and the gut. Eur J Biochem 164:553–557, 1987 Google Scholar
Ørskov C, Holst JJ, Knuhtsen S, Baldissera FGA, Poulsen SS, Nielsen OV: Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from the pig small intestine, but not pancreas. Endocrinology 119:1467–1475, 1986 Google Scholar
Holst JJ: Enteroglucagon. Adv Metab Dis 11:392–419, 1988 Google Scholar
Ørskov C, Holst JJ, Poulsen SS, Kirkegaard P: Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874–881, 1987 Google Scholar
Holst JJ, Ørskov C, Nielsen OV, Schwartz TW: Truncated glucagon-like 1, an insulin-releasing hormone from distal gut. FEBS Lett 211:169–174, 1987 Google Scholar
Ørskov C, Bersani M, Johnsen AH, Højrup P, Holst JJ: Complete sequence of glucagon-like peptide (GLP-1) from human and pig small intestine. J Biol Chem 264:12826–12829 1989 Google Scholar
Kreyman B, Ghatei MA, Williams G, Bloom SR: Glucagon-like peptide 1 7–36: A physiological incretin in man. Lancet 2:1300–1304, 1987 Google Scholar
Mojsov S, Weir GO, Habener JF: Insulinotropin: Glucagon-like peptide 1 (7–37) coencoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:616–619, 1987 Google Scholar
Ørskov C, Holst JJ, Nielsen OV: Effect of truncated glucagon-like peptide-1 (proglucagon 78–107-amide) on endocrine secretion from pig pancreas, antrum, and stomach. Endocrinology 123:2009–2013, 1988 Google Scholar
Christiansen J, Holst JJ, Kalaja E: Inhibition of gastric acid in man by exogenous and endogenous pancreatic glucagon. Gastroenterology 70:688–692, 1976 Google Scholar
Schjoldager BTG, Baldissera FGA, Mortensen PE, Holst JJ, Christiansen J: Oxyntomodulin: A potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur J Clin Invest 18:499–503, 1988 Google Scholar
Schjoldager BTG, Mortensen PE, Myhren J, Christiansen J, Holst JJ: Oxyntomodulin from distal gut: Role in regulation of gastric and pancreatic function. Dig Dis Sci 34:1411–1419, 1989 Google Scholar
Schjoldager BTG, Mortensen PE, Christiansen J, Ørskov C, Holst JJ: GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of the human proglucagon, inhibit gastric acid secretion in humans. Dig Dis Sci 34:703–708, 1989 Google Scholar
O'Halloran DJ, Nikou GC, Kreyman B, Ghatei MA, Bloom SR: Glucagon-like peptide-1 (7–36)-NH2: A physiological inhibitor of the gastric acid secretion in man. J Endocrinol 126:169–173, 1990 Google Scholar
Ørskov C, Holst JJ: Radioimmunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2). Scand J Clin Lab Invest 47:165–174, 1987 Google Scholar
Schjoldager BTG, Lawaetz O, Christiansen J: Effect of pancreatic glucagon and its 1–21 fragment on gastric emptying in man. Scand J Gastroenterol 23:726–730, 1988 Google Scholar
Lawaetz O, Ohlsen HP, Andreasen R: Evaluation of gastric emptying by a single isotope technique. Scand J Gastroenterol 16:737–748, 1981 Google Scholar
Go VLW, Hofmann AF, Summerskill WHJ: Simultaneous measurements of total pancreatic, biliary and gastric outputs in man using a perfusion technic. Gastroenterology 58:321–328, 1970 Google Scholar
Dimagno EP: Alternations and consequences of interdigestive and poststimulatory human exocrine pancreatic secretion in health and disease. Scand J Gastroenterol 12(suppl 87): 69, 1983 Google Scholar
Worning H, Müllertz S: pH and pancreatic enzymes in the human duodenum during digestion of a standard meal. Scand J Gastroenterol 1:268–283, 1966 Google Scholar
Ørskov C, Jeppesen J, Madsbad S, Holst JJ: Proglucagon products in plasma of non-insulindependent diabetics and nondiabetic controls in the fasting state and following oral glucose and intravenous arginine. J Clin Invest 87:415–423, 1991 Google Scholar
Holst JJ, Creutzfeldt M, Holm G, Jensen E, Poulsen D, Sparsø B, Schmidt A: Persistent glucagonemia after pancreatectomy in pigs. Diabete Metab 4:75–79, 1978 Google Scholar
Stadil F, Refeldt JF: Determination of gastrin in serum. Scand J Gastrenterol 8:101, 1973 Google Scholar
Albanc JDM, Ekins RP, Maritz G, Turner RC: A sensitive precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free serum hormone moieties. Acta Endocrinol (Kbh) 70:487–509, 1972 Google Scholar
Widdonson GM, Penton JR: Determination of serum and plasma glucose on “autoanalyzer II” by use of hexokinase reaction. Clin Chem 18:299–300, 1972 Google Scholar
Malagelada J-R, Longstreth GF, Summerskill WHJ, Go VLW: Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology 70:203–210, 1976 Google Scholar
Debas HT: Peripheral regulation of gastric secretion.In Physiology of the Gastrointestinal Tract, 2nd ed. LR Johnson (ed). New York, Raven Press, 1987, pp 931–945 Google Scholar
Solomon TE: Control of exocrine pancreatic secretion.In Physiology of the Gastrointestinal Tract, 2nd ed. LR Johnson (ed). New York, Raven Press, 1987, pp 1173–1208 Google Scholar
Kosaka T, Lim RKS: Demonstration of the humoral agent in fat inhibition of gastric secretion. Proc Soc Exp Biol Med 27:890–891, 1980 Google Scholar
Harper AA, Hood AJC, Mushens J, Smy JR: Pancreotone, an, inhibitor of pancreatic secretion in extracts of ileal and colonic mucosa. J Physiol (London) 292:455–467, 1979 Google Scholar
Olsen PS, Pedersen JH, Kirkegaard P, Been H, Stadil F: Neurotensin induced inhibition of acid secretion in duodenal ulcer patients before and after vagotomy. Gut 25:481–484, 1984 Google Scholar
Mogard MH, Maxwell VE, Sytnik B, Walsh JH: Regulation of gastric acid secretion by neurotensin in man: Evidence against a hormonal role. J Clin Invest 80:1064–1067, 1987 Google Scholar
Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, Bloom SR: Effect of peptide YY on gastric, pancreatic and biliary functions in humans. Gastroenterology 89:494–499, 1985 Google Scholar
Luis F, Gomez G, Fujinura M, Greeley GH Jr, Thompson JC: Peptide YY inhibits nutrient, hormonal and vagally stimulated pancreatic exocrine secretion. Pancreas 2:454–462, 1987 Google Scholar
Böttcher G, Sjölund K, Ekblad E, Håkanson R, Schwartz T, Sundler F: Coexistence of PYY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept 8:261–266, 1984 Google Scholar
Kirkegaard P, Loud FB, Moody AJ, Holst JJ, Christiansen J: Gut GLI inhibits gastric acid secretion in the rat. Nature 297:156–157, 1982 Google Scholar
Miholic J, Ørskov C, Holst JJ, Kotserke J, Meyer HJ: Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Dig Dis Sci 36:1361–1370, 1991 Google Scholar
Holst JJ, Rasmussen TN, Harling H, Schmidt P: Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas. Pancreas (in press)
Ørskov C: Glucagon-like peptide-1. Diabetologia 35:701–711, 1992 Google Scholar
Gutniak M, Ørskov C, Holst JJ, Ahren B, Efendic S: Antidiabetogenic effect of glucagon-like peptide-1 (7–36)amide in normal subjects and patients with diabetes, mellitus. N Engl J Med 326:1316–1322, 1992 Google Scholar